Table 3 Number and proportion of each gestational group exceeding the upper or lower limit of the non-pregnant RIs.

From: Reference intervals for coagulation parameters in non-pregnant and pregnant women

Test

4–12 W, n/N (%)

13–20 W, n/N (%)

21–27 W, n/N (%)

28–33 W, n/N (%)

34–42 W, n/N (%)

AT < 83.00%

26/237(10.97)

36/156(23.08)

54/168(32.14)

30/174(17.24)

59/143(41.26)

PC > 136.20%

5/237(2.11)

21/156(13.46)

31/168(18.45)

36/175(20.57)

21/143(14.69)

fPS < 59.48%

143/237(60.34)

97/156(62.18)

153/168(91.07)

160/175(91.43)

132/143(92.31)

LA normalized ratio > 1.22

5/237(2.11)

2/156(1.28)

4/167(2.40)

12/175(6.86)

11/143(7.69)

D-dimer > 0.18 μg/ml

31/297(10.44)

108/198(54.55)

144/168(85.71)

185/192(96.35)

206/206(100)

FDP > 1.60 μg/ml

24/297(8.08)

61/198(30.81)

99/168(58.93)

157/192(81.77)

201/206(97.57)

FVII > 129.01%

11/147(7.48)

61/132(46.21)

99/134(73.88)

103/126(81.75)

119/128(92.97)

FVIII > 227.36%

5/147(3.40)

7/132(5.30)

40/134(29.85)

53/126(42.06)

48/128(37.50)

  1. AT antithrombin, PC protein C, fPS free protein S, LA normalized ratio lupus anticoagulant normalized ratio, FDP fibrin/fibrinogen degradation products, FVII factor VII, FVIII factor VIII, W weeks, RIs reference intervals; n, number of gestational groups exceeding the upper or lower limit of the non-gestational RI, N number of pregnant groups.